SION - CIK 0002036042
Sionna Therapeutics, Inc. (SION) reported net income of -$75.27M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$75.27M | -22.0% |
| FY 2024 | -$61.69M | - |
Sionna Therapeutics, Inc. (SION) reported net income of -$75.27M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.